Insulet
PODD
#1971
Rank
C$14.42 B
Marketcap
C$207.96
Share price
0.03%
Change (1 day)
-54.88%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): C$8.37

According to Insulet's latest financial reports the company's current EPS (TTM) is C$8.50. In 2024 the company made an earnings per share (EPS) of C$8.56 an increase over its 2023 EPS that were of C$4.22.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$8.37
2024C$8.56102.71%
2023C$4.224114.29%
2022C$0.10-69.57%
2021C$0.33109.09%
2020C$0.16-38.89%
2019C$0.26200%
2018C$0.08585-113.04%
2017C-$0.66-9.8%
2016C-$0.73-60.47%
2015C-$1.8538.71%
2014C-$1.3312.05%
2013C-$1.19-23.15%
2012C-$1.55-12.2%
2011C-$1.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.56 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$3.87-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.84-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$44.20 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
C-$1.33-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$1.72-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$3.71-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA